Eric Lefkofsky: Co-Founder Of Tempus Helps Physicians Make Real-Time, Data-Driven Decisions

Eric Lefkofsky, Chicago-based entrepreneur and respected professor, is the co-founder of a unique technology company called Tempus. Strong supporters of his philanthropic contribution to humanity, his staff knows him very well and understands the importance of his vision: Through a suite of interactive analytical and machine learning technologies, Tempus is a resourceful cancer care service provider of analyzed molecular and therapeutic data, as well as genomic sequencing services.

At the Illinois-based company, Lefkofsky and his staff have led the way to build the largest and most updated library of molecular clinical data in the world. Many physicians have used the information with which to make well-informed decisions with which to care for their cancer patients.

Moreover, Tempus has developed an operating system with which to make the clinical data accessible to physicians and useful for personalized cancer care vital to cancer patients and their loved ones. With the real-time, Tempus has empowered physicians to be better cancer care service provider.

Without doubt, Eric Lefkofsky is making a huge difference:

He co-founded Tempus.

• He co-founded Tempus.
Lefkofsky has made philanthropic contribution to humanity.

• Lefkofsky has made philanthropic contribution to humanity.
He helps well-trained physicians make well-informed decisions.

• He helps well-trained physicians make well-informed decisions.
The philanthropist has continued helping patients live the best life possible.

• The philanthropist has continued helping patients live the best life possible. He and his staff has built the largest library of molecular and clinical data in the world.

• He and his staff has built the largest library of molecular and clinical data in the world. He has pledged pay it forward by giving away at least fifty percent of his wealth to philanthropy.

• He has pledged pay it forward by giving away at least fifty percent of his wealth to philanthropy. Tempus’ goal is open and transparent:

Lefkofsky and his staff provide each cancer care patient the much-needed services and treatment that they deserve, and can expect. Most important, Tempus provides physicians an operating system with which to care for their patients and to battle cancer.

To learn more about Tempus, visit the company’s official website at www.tempus.com, Twitter (@TempusLabs), and/or follow them on Facebook (Tempus Labs). To learn more information on Eric Lefkofsky, visit his website at www.lefkofsky.com right now.

To Know More Click Here

Eric Lefkofsky Is Committed To Helping Patients Kiss Cancer Goodbye

Gaining and maintaining success in today’s competitive world holds several challenges. This is why, so often, those who strive to be successful are passionate about the misfortune of others. Such is the case with Eric Lefkofsky, American businessman, and co-founder of Tempus, a technology company whose main objective is to enhance cancer treatment options for patients that face it. After watching a loved one tirelessly battle the disease, he knew he had to do something. So, in 2015, Lefkofsky and co-partner Brad Keywell began their own sort of battle with the complex disease, setting themselves out on a mission to empower and change the lives of all who had been diagnosed.

Always committed to helping others, both Lefkofsky and his wife, Elizabeth formed a charitable trust in 2006. The Lefkofsky Foundation focuses on factors such as education, human rights, and medical research. In March of 2016, the compassionate couple became proud financial supports of The Academy for Urban School, a non-profit organization that works to help strengthen relationships and the learning environment in Chicago’s Public Schools. While most of his philanthropic efforts are focused on his hometown of Chicago, Lefkofsky has made countless contributions to other organizations who support the same causes.

Feeling that too often, we take the world for granted because of our unconscious decision to only see it through our own eyes, Lefkofsky says that he remains empathetic in both business and philanthropy. It is the key to his success. Understanding that there is a possibility of someone having a problem that may actually be greater than your own. It is that empathy, that compassion that has been his main motivator, and as he says, the business itself is all about motivation.

This belief led him to where he is today. When he isn’t busy running one of his many successful businesses, you can likely find him having a one on one with local doctors and patients who are battling cancer. With their help, he truly believes we can finally have hope in cancer treatment technology.

To Learn More Click Here

Eric Lefkovsky – Making A Life-Changing Difference

Eric Lefkovsky is a Chicago billionaire, who wants to facilitate change about the way the medical community fights cancer. He launched Tempus Labs to enhance how cancer patients are diagnosed. Tempus is highly focused on the available data, and so is Lefkovsky. The company partners with premier institutions of higher learning, as well as NCI-designated cancer centers, to gather cancer patient data, They subsequently consolidate and organize it, so the information can be disseminated to doctors, who can use it to create treatment plans which are tailored specifically to each patient.

According to Lefkovsky, the best treatment approach utilizes both clinical data and the information in the patient’s health profile, which he cites as molecular data. He is referring to the patient’s genetic makeup (DNA and RNA). Ultimately, Tempus’ goal is to use the collected data in combination with science and technology advances, and human genome sequencing to promote improved cancer treatment.

Eric Lefkovsky is the co-founder of several companies, including Groupon, Uptake, Echo Global Logistics, Inner-Workings, and Lightbank. He is currently an adjunct professor at the University of Chicago’s Booth School of Business but formerly held teaching positions at the Kellogg School of Management at Northwestern University, and the Kellstadt Graduate School of Business at DePaul University.

He is an enthusiastic philanthropist. Eric and his wife founded the Lefkovsky Family Foundation, which is focused on the advance of “high-impact initiatives that enhance the quality of human life”. They promote these goals through donations in the areas of medicine, human rights, art and culture, and education. Eric and Liz are both members of The Giving Pledge. He is Chairman of the Board of Trustees for the Steppenwolf Theatre Company, based in Chicago. Lefkovsky is a board member of several organizations, which include the Lurie’s Children Hospital of Chicago, The Museum of Science and History, The Art Institute of Chicago, and World Business Chicago.

Eric Lefkovsky has personal and profiles on Facebook, Twitter, and LinkedIn. His social media profiles, especially his Twitter feed show where his interests lie. His focus is on cancer treatment and other organizations where he is involved.

Contact Eric Lefkovsky : www.facebook.com/eplefkofsky/

Will Eric Lefkofsky Improve Cancer Diagnosis And Treatment Through Tempus?

It is certain that Cancer is still a dilemma and continues to affect millions of people worldwide. However, the last decade has seen remarkable progress in the fight against cancer. Researchers have discovered new cancer treatments and therapies. Governments have also joined the fight and are coming up with new policies and regulations that are aimed at stemming the tide of this devastating disease worldwide. There are innovative programs, initiatives, and strategies that have been formed to help accelerate current and future developments against cancer. New companies are also coming up and are changing the way we treat cancer. One such company is Tempus, a revolutionary technology company that has built an innovative operating system that will bring a smart approach in the fight against cancer.

About Tempus

Tempus was founded in 2015 by renowned tech figures, Eric Lefkofsky and Brad Keywell. The company focuses on collecting, analyzing, and storing of large clinical data, which, according to the company’s website, will help doctors make real time, individualized, and data-driven decisions. The duo says that the start-up uses sophisticated genomic sequencing and data analysis techniques that will help come up with the next breakthrough developments in the battle against cancer.

The company works with patients who have lung, pancreatic, and breast cancer and hopes to focus on other forms of cancer over time. The innovative start-up also expects to collaborate with researchers, cancer programs, and hospitals to collect more accurate data and make their system more efficient. They recently announced that they would work with hospitals such as Northwestern’s Lurie Cancer Center, Cleveland Clinic, University of Michigan, Duke University School of Medicine, and other community cancer clinics across the country.

Eric Lefkofsky

Eric Lefkofsky is an influential American entrepreneur. He is Co-founder and the current CEO of Tempus. He is also the man behind Lightbank, a Chicago-based venture capital firm that bets on emerging and disruptive start-ups. Lefkofsky contribution in the fight against cancer did not start at Tempus; he and his wife, Elizabeth, have been making large donations to help cancer researchers come up with technologies and treatments options that can help eradicate cancer.

Thanks to his leadership skills and years of experience, the exceptional leader has been able to transform Tempus from a weak start-up into an invincible force in the medical world. The company is currently valued $700 million.

To Learn More Click Here

Eric Lefkofsky’s Achievements

Eric Lefkofsky is the CEO and co-founder of Tempus, which is a technology company that has built a super operating system to be used in battling cancer. Eric is also a founding partner of Lightbank, a company that ventures in fund investment in matters to do with disruptive technologies. On the other hand, he is the chairman and co-founder of Groupon, an e-commerce marketplace globally as well as a co-founder of Uptake Technologies. Uptake Technologies is one of the world’s largest industries in predicting analytics platform. Echo Global Logistics is a logistic outsourcing and technology-enabled transportation firm, and Inner Workings is a provider of managed promotional and print solutions globally.

Tempus mission is to redefine the way genomic data is used and applied in a clinical setting. The company’s major goal is to ensure that each and every patient benefits fully from the treatment of those individuals who come before by ensuring they provide physicians with the adequate tools that learn and gather more data. Also, the company provides transcriptomic and genomic services and analyzes germline and somatic molecular data along with therapeutical data to ensure they empower physicians to make a compelling data-driven decision.

In the year 2006, Lefkofsky together with his wife formed a charitable trust by the name Lefkofsky Family Foundation. Its mission is to support charitable and educational organizations, scientific and causes around the entire world. The Foundation’s primary purpose is to ensure that advance initiatives and high impact programs can improve the living standards of human life in the communities. The foundation focuses on human rights, education, arts and culture, and medical research. The grant making is always evaluated quarterly, and higher part of the money is focused on Chicago which is Lefkofskys’ hometown, whereby arts and culture take the largest donations.

Eric’s education support initiative focuses on Greater Chicago area where they engage in helping younger children as well as giving charters to schools, scholarship programs and after-school programs for the disadvantaged youth. The foundation also engages in supporting medical centers particularly those that care for children as well as give donations to pancreatic cancer. Also, Lefkofskys has supported research in the treatment as well as the cure for lung cancer, thyroid cancer, and leukemia. The foundation has also partnered with Motorola Mobility and Google to create 1871 FEMtech, with the hope and goal of enabling and encouraging more female tech to break into the field as entrepreneurs.